The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.
Open accessAbstract
Tyrosinase was the first melanoma-associated antigen shown to be recognized by CD4+ T cells. In this study, we have identified two HLA-DRB1*0401-restricted peptides recognized by these T cells: Ty 56-70 and Ty 448-462. As with many of the MHC class I-restricted melanoma epitopes, both are nonmutated self peptides that have intermediate and weak MHC binding affinities, respectively. Mutated and truncated versions of these peptides were used to define their MHC binding anchor residues. Anchor residues were then modified to derive peptides with increased MHC binding affinities and T cell stimulatory properties. Ty 56-70 and Ty 448-462 enhance the list of immunogenic HLA-A2-, A24-, and B44-restricted tyrosinase peptides already described. Thus, tyrosinase provides a model for anti-melanoma vaccines in which a single molecule can generate multivalent immunization incorporating both CD4+ and CD8+ T cell responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L., & Wiley, D. C. (1993) · Nature · doi:10.1038/364033a0 · Cited by 2,379
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Sequence analysis of peptides bound to MHC class II molecules
Rudensky, A. Y., Preston-Hurlburt, P., Hong, S.-C., Barlow, A., & Janeway, C. A. (1991) · Nature · doi:10.1038/353622a0 · Cited by 1,075
Coulie, P. G., Brichard, V, Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.35 · Cited by 903
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.
Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A., Lane, W. S., & Strominger, J. L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.27 · Cited by 887
Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., & Rosenberg, S. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.347 · Cited by 862
Self-citationChicz, R. M., Urban, R. G., Lane, W. S., Gorga, J. C., Stern, L. J., Vignali, D. A. A., & Strominger, J. L. (1992) · Nature · doi:10.1038/358764a0 · Cited by 768
Hunt, D. F., Michel, H., Dickinson, T. A., Shabanowitz, J., Cox, A. L., Sakaguchi, K., Appella, E., Grey, H. M., & Sette, A. (1992) · Science · doi:10.1126/science.1319610 · Cited by 646
Self-citationRobbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., & Rosenberg, S. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1185 · Cited by 550
Self-citationKawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., & Rosenberg, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3961 · Cited by 540
Self-citationTumor-specific cytolysis by lymphocytes infiltrating human melanomas.
Topalian, S. L., Solomon, D., & Rosenberg, S. A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.10.3714 · Cited by 512
Self-citationIsolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus.
Kwon, B. S., Haq, A. K., Pomerantz, S. H., & Halaban, R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7473 · Cited by 438
Isolation and characterization of the intracellular MHC class II compartment
Tulp, A., Verwoerd, D., Dobberstein, B., Ploegh, H. L., & Pieters, J. (1994) · Nature · doi:10.1038/369120a0 · Cited by 424
Two tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes
Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Zum Büschenfelde, K. M., & Boon, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240340 · Cited by 411
Topalian, S. L., Rivoltini, L., Mancini, M., Markus, N. R., Robbins, P. F., Kawakami, Y., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9461 · Cited by 286
Self-citationInduction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA.
Bouchard, B., Fuller, B. B., Vijayasaradhi, S., & Houghton, A. N. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.6.2029 · Cited by 179
Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
Chen, Y. T., Stockert, E., Tsang, S., Coplan, K. A., & Old, L. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8125 · Cited by 176
Vijayasaradhi, S., Xu, Y., Bouchard, B., & Houghton, A. N. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.130.4.807 · Cited by 153
Sette, A., Sidney, J., Oseroff, C., del Guercio, M. F., Southwood, S., Arrhenius, T. S., Powell, M. F., Colon, S. M., Gaeta, F. C., & Grey, H. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.6.3163 · Cited by 148
Self-citationMHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy
Topalian, S. L. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90078-7 · Cited by 100
Self-citationHLA-DR3 molecules can bind peptides carrying two alternative specific submotifs.
Geluk, A., van Meijgaarden, K. E., Southwood, S., Oseroff, C., Drijfhout, J. W., de Vries, R. R., Ottenhoff, T. H. M., & Sette, A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.12.5742 · Cited by 82
Self-citationZhou, B.-K., Boissy, R. E., Pifko‐Hirst, S., Moran, D. J., & Orlow, S. J. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12462775 · Cited by 61
Lipford, G. B., Bauer, S., Wagner, H., et al. (1995) · Vaccine · doi:10.1016/0264-410x(95)93320-9 · Cited by 50
Cited by
Thurner, B., Haendle, I., Röder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., von den Driesch, P., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1669 · Cited by 1,226
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P., & Boon, T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3670 · Cited by 1,138
Sturniolo, T., Bono, E., Ding, J., Raddrizzani, L., Tuereci, O., Sahin, U., Braxenthaler, M., Gallazzi, F., Protti, M. P., Sinigaglia, F., et al. (1999) · Nature Biotechnology · doi:10.1038/9858 · Cited by 743
A listing of human tumor antigens recognized by T cells
Renkvist, N., Castelli, C., Robbins, P. F., & Parmiani, G. (2001) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620000169 · Cited by 694
Self-citationThe role of CD4+ T cell responses in antitumor immunity
Pardoll, D. M., & Topalian, S. L. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80228-8 · Cited by 672
Self-citation
Metadata
- Authors
- Topalian, S. L., Gonzales, M. I., Parkhurst, M., Li, Y. F., Southwood, S., Sette, A., Rosenberg, S. A., & Robbins, P. F.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-05-01
- Volume
- 183
- Issue
- 5
- Pages
- 1965-1971
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2028852768
- Cited by
- 257
- References
- 24
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.